Ben Hirschler on Muck Rack

Ben Hirschler Verified

Pharma, Health and Science Correspondent — Reuters

Pharma, health and science writer at Reuters. Any opinions are mine.

Sep 16, 2014

#Roche CEO tells us his $8B #InterMune acquisition not a signal for more big deals and he "happy" with #Chugai setup

Sep 16, 2014

Betting on BACE inhibition --> #AstraZeneca to get up to $500M from #Lilly under #Alzheimer's drug partnership deal

Sep 15, 2014

Reuters Farmaceuticals: the drugs fed to farm animals and the risks posed to humans… via @SpecialReports

Sep 15, 2014

#Gilead licenses #hepatitis C drug to 7 Indian firms <--important news but will it ensure comprehensive access?

Sep 15, 2014

Another day, another deal ... #Danaher to buy #Nobel Biocare Holding for $2.2B, including debt

Sep 15, 2014

RT @epaultaylor: Study suggests a cheaper alternative to a costly eye drug used to treat macular degeneration. By @reutersBenHir…

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


For instructions on how to pitch Ben Hirschler, email

Share This Profile